Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance

Geetha Kannan, Manlio Di Cristina, Aric J. Schultz, My Hang Huynh, Fengrong Wang, Tracey L. Schultz, Matteo Lunghi, Isabelle Coppens, Vern B. Carruthersa

Research output: Contribution to journalArticle

Abstract

Toxoplasma gondii is a ubiquitous pathogen that can cause encephalitis, congenital defects, and ocular disease. T. gondii has also been implicated as a risk factor for mental illness in humans. The parasite persists in the brain as slowgrowing bradyzoites contained within intracellular cysts. No treatments exist to eliminate this form of parasite. Although proteolytic degradation within the parasite lysosome-like vacuolar compartment (VAC) is critical for bradyzoite viability, whether other aspects of the VAC are important for parasite persistence remains unknown. An ortholog of Plasmodium falciparum chloroquine resistance transporter (CRT), TgCRT, has previously been identified in T. gondii. To interrogate the function of TgCRT in chronic-stage bradyzoites and its role in persistence, we knocked out TgCRT in a cystogenic strain and assessed VAC size, VAC digestion of host-derived proteins and parasite autophagosomes, and the viability of in vitro and in vivo bradyzoites. We found that whereas parasites deficient in TgCRT exhibit normal digestion within the VAC, they display a markedly distended VAC and their viability is compromised both in vitro and in vivo. Interestingly, impairing VAC proteolysis in TgCRT-deficient bradyzoites restored VAC size, consistent with a role for TgCRT as a transporter of products of digestion from the VAC. In conjunction with earlier studies, our current findings suggest a functional link between TgCRT and VAC proteolysis. This study provides further evidence of a crucial role for the VAC in bradyzoite persistence and a new potential VAC target to abate chronic Toxoplasma infection.

Original languageEnglish (US)
Article numbere01324-19
JournalmBio
Volume10
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Chloroquine
Vacuoles
Parasites
Maintenance
Toxoplasma
Digestion
Proteolysis
Eye Diseases
Encephalitis
Lysosomes
Cysts
Brain
Infection
Proteins

Keywords

  • Autophagy
  • Persistence
  • Proteolysis
  • Toxoplasma gondii
  • Transporters

ASJC Scopus subject areas

  • Microbiology
  • Virology

Cite this

Kannan, G., Di Cristina, M., Schultz, A. J., Huynh, M. H., Wang, F., Schultz, T. L., ... Carruthersa, V. B. (2019). Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance. mBio, 10(4), [e01324-19]. https://doi.org/10.1128/mBio.01324-19

Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance. / Kannan, Geetha; Di Cristina, Manlio; Schultz, Aric J.; Huynh, My Hang; Wang, Fengrong; Schultz, Tracey L.; Lunghi, Matteo; Coppens, Isabelle; Carruthersa, Vern B.

In: mBio, Vol. 10, No. 4, e01324-19, 01.01.2019.

Research output: Contribution to journalArticle

Kannan, G, Di Cristina, M, Schultz, AJ, Huynh, MH, Wang, F, Schultz, TL, Lunghi, M, Coppens, I & Carruthersa, VB 2019, 'Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance', mBio, vol. 10, no. 4, e01324-19. https://doi.org/10.1128/mBio.01324-19
Kannan, Geetha ; Di Cristina, Manlio ; Schultz, Aric J. ; Huynh, My Hang ; Wang, Fengrong ; Schultz, Tracey L. ; Lunghi, Matteo ; Coppens, Isabelle ; Carruthersa, Vern B. / Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance. In: mBio. 2019 ; Vol. 10, No. 4.
@article{921614d3bacc4d86b6ab42852d1aa381,
title = "Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance",
abstract = "Toxoplasma gondii is a ubiquitous pathogen that can cause encephalitis, congenital defects, and ocular disease. T. gondii has also been implicated as a risk factor for mental illness in humans. The parasite persists in the brain as slowgrowing bradyzoites contained within intracellular cysts. No treatments exist to eliminate this form of parasite. Although proteolytic degradation within the parasite lysosome-like vacuolar compartment (VAC) is critical for bradyzoite viability, whether other aspects of the VAC are important for parasite persistence remains unknown. An ortholog of Plasmodium falciparum chloroquine resistance transporter (CRT), TgCRT, has previously been identified in T. gondii. To interrogate the function of TgCRT in chronic-stage bradyzoites and its role in persistence, we knocked out TgCRT in a cystogenic strain and assessed VAC size, VAC digestion of host-derived proteins and parasite autophagosomes, and the viability of in vitro and in vivo bradyzoites. We found that whereas parasites deficient in TgCRT exhibit normal digestion within the VAC, they display a markedly distended VAC and their viability is compromised both in vitro and in vivo. Interestingly, impairing VAC proteolysis in TgCRT-deficient bradyzoites restored VAC size, consistent with a role for TgCRT as a transporter of products of digestion from the VAC. In conjunction with earlier studies, our current findings suggest a functional link between TgCRT and VAC proteolysis. This study provides further evidence of a crucial role for the VAC in bradyzoite persistence and a new potential VAC target to abate chronic Toxoplasma infection.",
keywords = "Autophagy, Persistence, Proteolysis, Toxoplasma gondii, Transporters",
author = "Geetha Kannan and {Di Cristina}, Manlio and Schultz, {Aric J.} and Huynh, {My Hang} and Fengrong Wang and Schultz, {Tracey L.} and Matteo Lunghi and Isabelle Coppens and Carruthersa, {Vern B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1128/mBio.01324-19",
language = "English (US)",
volume = "10",
journal = "mBio",
issn = "2161-2129",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Role of to xo plasma gondii chloroquine resistance transporter in bradyzoite viability and digestive vacuole maintenance

AU - Kannan, Geetha

AU - Di Cristina, Manlio

AU - Schultz, Aric J.

AU - Huynh, My Hang

AU - Wang, Fengrong

AU - Schultz, Tracey L.

AU - Lunghi, Matteo

AU - Coppens, Isabelle

AU - Carruthersa, Vern B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Toxoplasma gondii is a ubiquitous pathogen that can cause encephalitis, congenital defects, and ocular disease. T. gondii has also been implicated as a risk factor for mental illness in humans. The parasite persists in the brain as slowgrowing bradyzoites contained within intracellular cysts. No treatments exist to eliminate this form of parasite. Although proteolytic degradation within the parasite lysosome-like vacuolar compartment (VAC) is critical for bradyzoite viability, whether other aspects of the VAC are important for parasite persistence remains unknown. An ortholog of Plasmodium falciparum chloroquine resistance transporter (CRT), TgCRT, has previously been identified in T. gondii. To interrogate the function of TgCRT in chronic-stage bradyzoites and its role in persistence, we knocked out TgCRT in a cystogenic strain and assessed VAC size, VAC digestion of host-derived proteins and parasite autophagosomes, and the viability of in vitro and in vivo bradyzoites. We found that whereas parasites deficient in TgCRT exhibit normal digestion within the VAC, they display a markedly distended VAC and their viability is compromised both in vitro and in vivo. Interestingly, impairing VAC proteolysis in TgCRT-deficient bradyzoites restored VAC size, consistent with a role for TgCRT as a transporter of products of digestion from the VAC. In conjunction with earlier studies, our current findings suggest a functional link between TgCRT and VAC proteolysis. This study provides further evidence of a crucial role for the VAC in bradyzoite persistence and a new potential VAC target to abate chronic Toxoplasma infection.

AB - Toxoplasma gondii is a ubiquitous pathogen that can cause encephalitis, congenital defects, and ocular disease. T. gondii has also been implicated as a risk factor for mental illness in humans. The parasite persists in the brain as slowgrowing bradyzoites contained within intracellular cysts. No treatments exist to eliminate this form of parasite. Although proteolytic degradation within the parasite lysosome-like vacuolar compartment (VAC) is critical for bradyzoite viability, whether other aspects of the VAC are important for parasite persistence remains unknown. An ortholog of Plasmodium falciparum chloroquine resistance transporter (CRT), TgCRT, has previously been identified in T. gondii. To interrogate the function of TgCRT in chronic-stage bradyzoites and its role in persistence, we knocked out TgCRT in a cystogenic strain and assessed VAC size, VAC digestion of host-derived proteins and parasite autophagosomes, and the viability of in vitro and in vivo bradyzoites. We found that whereas parasites deficient in TgCRT exhibit normal digestion within the VAC, they display a markedly distended VAC and their viability is compromised both in vitro and in vivo. Interestingly, impairing VAC proteolysis in TgCRT-deficient bradyzoites restored VAC size, consistent with a role for TgCRT as a transporter of products of digestion from the VAC. In conjunction with earlier studies, our current findings suggest a functional link between TgCRT and VAC proteolysis. This study provides further evidence of a crucial role for the VAC in bradyzoite persistence and a new potential VAC target to abate chronic Toxoplasma infection.

KW - Autophagy

KW - Persistence

KW - Proteolysis

KW - Toxoplasma gondii

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=85071173172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071173172&partnerID=8YFLogxK

U2 - 10.1128/mBio.01324-19

DO - 10.1128/mBio.01324-19

M3 - Article

C2 - 31387907

AN - SCOPUS:85071173172

VL - 10

JO - mBio

JF - mBio

SN - 2161-2129

IS - 4

M1 - e01324-19

ER -